Preparation and evaluation of amino acid conjugates of celecoxib as prodrugs to improve the pharmacokinetic and therapeutic properties of celecoxib

Yonghyun Lee, Jungyun Kim, Wooseong Kim, In Soo Yoon, Yunjin Jung

Research output: Contribution to journalArticlepeer-review

Abstract

Although celecoxib is quite effective in the management of inflammation-related diseases, especially arthritis, its use is limited by concerns including low bioavailability (BA), non-linear pharmacokinetic (PK) profile, and peak concentration-related toxicity. To overcome these issues, we designed and prepared hydrophilic celecoxib prodrugs, namely N-glycyl-aspart-1yl celecoxib (N-GA1C), glutam-1-yl celecoxib (G1C), and aspart-1yl celecoxib (A1C), for the sustained release of celecoxib in the intestine with limited systemic absorption. The celecoxib derivatives were converted to celecoxib in the intestinal contents. The conversion rates were in order of N-GA1C > G1C > A1C. Oral administration of the celecoxib derivatives (oral celecoxib derivatives) sustained the plasma concentration of celecoxib for 24 h, improving the BA and linearity of the PK profile of celecoxib. The peak concentrations (Cmax) of celecoxib after oral celecoxib derivatives were lower than that after oral celecoxib. In a carrageenan-induced rat paw edema model, oral N-GA1C exhibited greater anti-inflammatory activity for a longer duration compared with oral celecoxib. The order of efficacy of the celecoxib derivatives was N-GA1C > G1C > A1C. Taken together, the prodrug approach is a feasible strategy to improve the PK and therapeutic properties of celecoxib, and among the celecoxib derivatives, N-GA1C may be the most promising prodrug of celecoxib.

Original languageEnglish
Article number1043
Pages (from-to)1-13
Number of pages13
JournalPharmaceutics
Volume12
Issue number11
DOIs
StatePublished - Nov 2020

Keywords

  • Bioavailability
  • Carrageenan-induced rat paw edema model
  • Celecoxib
  • Extended absorption
  • PK linearity
  • Prodrug

Fingerprint

Dive into the research topics of 'Preparation and evaluation of amino acid conjugates of celecoxib as prodrugs to improve the pharmacokinetic and therapeutic properties of celecoxib'. Together they form a unique fingerprint.

Cite this